Clinical trial
A Comparison of the Drug Telbivudine (LdT) and Lamivudine in Adults With…
NCT00275652 · Mayo Clinic, Other · Completed
Key facts
| NCT number | NCT00275652 |
|---|---|
| Title | A Comparison of the Drug Telbivudine (LdT) and Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of Cirrhosis. |
| Official title | A Randomized, Double-Blind Trial of Telbivudine (LdT) Versus Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of Cirrhosis. |
| Lead sponsor | Mayo Clinic, Other |
| Collaborators | Merck Sharp & Dohme LLC Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hepatitis B, Cirrhosis |
| Intervention type | Drug |
| Interventions | LdT (Telbivudine) and lamivudine |
| Enrollment | 6 |
| Start date | Jun 1, 2004 |
| Primary completion | Aug 1, 2007 |
| Completion | Aug 1, 2007 |
| First posted | Jan 12, 2006 |
| Last update posted | Mar 23, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: